The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...
Jefferies analyst Stephen Barker maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) on January 19 and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback